Intestinal microbiome-gut-brain axis and irritable bowel syndrome; [Intestinale Mikrobiom-Darm-Hirn-Achse und Reizdarmsyndrom]

被引：66
作者：
Moser G. [1 ]
Fournier C. [1 ]
Peter J. [1 ]
机构：
[1] Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, Vienna
来源：
Wiener Medizinische Wochenschrift | 2018年 / 168卷 / 3-4期
关键词：
Anxiety; Depression; Enterotype; Psyche; Stress;
D O I：
10.1007/s10354-017-0592-0
中图分类号：
学科分类号：
摘要：
Psychological comorbidity is highly present in irritable bowel syndrome (IBS). Recent research points to a role of intestinal microbiota in visceral hypersensitivity, anxiety, and depression. Increased disease reactivity to psychological stress has been described too. A few clinical studies have attempted to identify features of dysbiosis in IBS. While animal studies revealed strong associations between stress and gut microbiota, studies in humans are rare. This review covers the most important studies on intestinal microbial correlates of psychological and clinical features in IBS, including stress, anxiety, and depression. © 2017, The Author(s).
引用
收藏
页码：62 / 66
页数：4
相关论文
共 63 条
[41]  
Stanculete M.F., Matu S., Pojoga C., Et al., Coping strategies and irrational beliefs as mediators of the health-related quality of life impairments in irritable bowel syndrome, J Gastrointest Liver Dis, 24, 2, pp. 159-164, (2015)
[42]  
Fond G., Loundou A., Hamdani N., Et al., Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis, Eur Arch Psychiatry Clin Neurosci, 264, 8, pp. 651-660, (2014)
[43]  
Moloney R.D., Johnson A.C., O'Mahony S.M., Et al., Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome, CNS Neurosci Ther, 22, 2, pp. 102-117, (2016)
[44]  
Claassen J., Labrenz F., Ernst T.M., Et al., Altered cerebellar activity in visceral pain-related fear conditioning in irritable bowel syndrome, Cerebellum, 16, 2, pp. 508-517, (2016)
[45]  
Schmid J., Langhorst J., Gass F., Et al., Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers, Gut, 64, 3, pp. 418-427, (2015)
[46]  
Simren M., Barbara G., Flint H.J., Et al., Intestinal microbiota in functional bowel disorders: a Rome foundation report, Gut, 62, 1, pp. 159-176, (2013)
[47]  
Casen C., Vebo H.C., Sekelja M., Et al., Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD, Aliment Pharmacol Ther, 42, 1, pp. 71-83, (2015)
[48]  
Jalanka J., Salonen A., Fuentes S., Et al., Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment, Gut Microbes, 6, 6, pp. 364-369, (2015)
[49]  
Jeffery I.B., O'Toole P.W., Ohman L., Et al., An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota, Gut, 61, 7, pp. 997-1006, (2012)
[50]  
Jeffery I., O'Toole P., Fraher M., Et al., Alterations in the microbiota in irritable bowel syndrome
1234567